CompuMed (OTCMKTS:CMPD) Issues Quarterly Earnings Results

CompuMed (OTCMKTS:CMPDGet Free Report) issued its quarterly earnings data on Monday. The company reported ($0.06) EPS for the quarter, Zacks reports. CompuMed had a negative return on equity of 1.88% and a negative net margin of 0.78%.

CompuMed Stock Performance

OTCMKTS CMPD remained flat at $6.75 during trading on Monday. 320 shares of the company’s stock traded hands, compared to its average volume of 477. The company has a current ratio of 2.04, a quick ratio of 2.01 and a debt-to-equity ratio of 0.16. CompuMed has a 1-year low of $1.95 and a 1-year high of $6.95. The firm has a market capitalization of $8.98 million, a P/E ratio of -134.97 and a beta of -0.53. The stock has a 50 day simple moving average of $6.22 and a two-hundred day simple moving average of $4.59.

CompuMed Company Profile

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

Featured Stories

Earnings History for CompuMed (OTCMKTS:CMPD)

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.